“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Bayer today announced topline results of the Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use in magnetic ...

Having been dropped by WME and sued by Blake Lively for sexual harassment and an alleged online smear campaign, Justin ...

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

European markets traded higher Wednesday as markets digested cooler-than-expected inflation data from the U.S. and UK.

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

We came across a long thesis on Corteva Inc (NYSE:CTVA) on ValueInvestorsClub by Glory_Warriors. In this article we will ...

Bayer has joined its peers among European drugmakers ... Among pharma watchers, all eyes are currently on key pharma prospects Kerendia (finerenone) for chronic kidney disease and prostate cancer ...

Leverkusen also became the headquarters for the I.G.'s pharmaceutical sales association, and the Bayer Cross was used as the trademark for all of the I.G.'s pharmaceutical products. In the early ...

Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...